Edition:
United Kingdom

Novozymes A/S (NZYMb.CO)

NZYMb.CO on Copenhagen Stock Exchange

317.90DKK
3:59pm GMT
Change (% chg)

kr.-1.10 (-0.34%)
Prev Close
kr.319.00
Open
kr.319.80
Day's High
kr.321.40
Day's Low
kr.314.80
Volume
373,934
Avg. Vol
508,230
52-wk High
kr.360.70
52-wk Low
kr.264.10

Latest Key Developments (Source: Significant Developments)

BioAg Alliance Announces Updated Research And Development Pipeline
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - BioAg Alliance::BIOAG ALLIANCE - ANNOUNCED UPDATED RESEARCH AND DEVELOPMENT PIPELINE.BIOAG ALLIANCE - SEES ACCELERON B-300 SAT TO BE APPLIED TO BETWEEN 8-10 MILLION ACRES IN 2018, WHILE ACCELERON B-360 ST SCHEDULED TO ENTER MARKET IN 2019.BIOAG ALLIANCE - IN 2019-2020, PLAN TO LAUNCH PRODUCTS FOR GROWERS OF CORN, OILSEED RAPE AND WHEAT IN EUROPE.  Full Article

Novozymes Appoints Prisca Havranek-Kosicek New CFO
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - NOVOZYMES ::PRISCA HAVRANEK-KOSICEK NEW CFO.  Full Article

Novozymes CEO Sells 50,000 Of Own Shares
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Novozymes ::CEO SELLS 50.000 OF OWN SHARES IN COMPANY FOR A TOTAL VALUE OF DKK 17.2 MILLION.  Full Article

Novozymes completes share buyback program
Friday, 10 Nov 2017 

Nov 10 (Reuters) - NOVOZYMES ::‍NOVOZYMES HAS NOW COMPLETED ANNOUNCED SHARE BUYBACK PROGRAM OF B SHARES WORTH UP TO DKK 2 BILLION IN TOTAL DURING 2017​.  Full Article

Novozymes Q3 EBIT above expectations at DKK 1.06 bln
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - NOVOZYMES ::‍FULL-YEAR OUTLOOK ADJUSTED​.‍NOW EXPECTS ORGANIC REVENUE GROWTH 3-5% (2-5%)​.NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4‍​.NOW EXPECTS ‍DKK REVENUE GROWTH 2-4% (1-4%)​.NOW EXPECTS ‍EBIT GROWTH 2-4% (1-4%)​.Q3 SALES DKK ‍​3.58 BILLION (REUTERS POLL DKK 3.54 BILLION).Q3 EBIT DKK ‍​1.06 BILLION (REUTERS POLL DKK 1.01 BILLION).Q3 NET PROFIT 819 MILLION (REUTERS POLL DKK 789 MILLION).  Full Article

Novozymes launches two ethanol enzyme products in Europe
Thursday, 17 Aug 2017 

Aug 17 (Reuters) - DANISH ENZYMES PRODUCER NOVOZYMES ANNOUNCES:LAUNCH OF SPIRIZYME 2.0 T AND SPIRIZYME ULTRA T FOR EUROPEAN ETHANOL MARKET.  Full Article

Novozymes Q2 EBIT DKK 961 million, below expectations
Wednesday, 10 Aug 2016 

Novozymes A/S : Q2 sales 3.43 billion Danish crowns ($512.6 million) (Reuters poll 3.55 billion crowns) . Q2 EBIT 961 million crowns (Reuters poll 981 million crowns) . Outlook for full-year organic sales growth is adjusted to 2-4 pct, down from previously 3-5 pct, to reflect uncertainty in most of the industries in which Novozymes operates. . FY outlook for each of EBIT, EBIT margin, net profit, net investments, free cash flow ROIC is unchanged .FY outlook for sales in Danish crowns is unchanged.  Full Article

Novozymes and DONG Energy sign deal on biological waste sorting
Wednesday, 29 Jun 2016 

Novozymes A/S : Novozymes and DONG Energy enter into agreement on biological waste sorting . Novozymes will deliver enzymes for coming renescience plant in Northwich in North West of England . Enzyme supply agreement is a long-term non-exclusive agreement .Novozymes and DONG Energy have also agreed to further develop enzymes for technology together.  Full Article

Novozymes cuts FY 2016 outlook for sales and EBIT growth in Danish crowns
Wednesday, 20 Apr 2016 

Novozymes A/S:Outlook for FY 2016 organic sales growth and for net profit growth is unchanged.The outlook for sales and EBIT growth in Danish crowns is adjusted from 3-5 percent to 1-3 percent to account for the lower currency exchange rates.  Full Article

Photo

European shares recover from seven-day losing streak

MILAN/LONDON European shares broke a seven-day losing streak on Wednesday as investors took heart from a recovery on Wall Street and reduced volatility, returning their focus to some upbeat company earnings.